The aim of this study was to evaluate the immunohistochemical (IHC) expression of Ki-67, estrogen receptors α (ERsα), and progesterone receptors (PRs) in high-risk endometrial cancer patients and to assess their prognostic impact.
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer / Di Donato, Violante; Iacobelli, Valentina; Schiavi, Michele Carlo; Colagiovanni, Vanessa; Pecorella, Irene; Palaia, Innocenza; Perniola, Giorgia; Marchetti, Claudia; Musella, Angela; Tomao, Federica; Monti, Marco; Muzii, Ludovico; Benedetti Panici, Pierluigi. - In: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. - ISSN 1048-891X. - STAMPA. - 28:3(2018), pp. 505-513. [10.1097/IGC.0000000000001191]
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer
Di Donato, Violante
Primo
;IACOBELLI, VALENTINASecondo
;Schiavi, Michele Carlo;Colagiovanni, Vanessa;Pecorella, Irene;Palaia, Innocenza;Perniola, Giorgia;Marchetti, Claudia;Musella, Angela;Tomao, Federica;Monti, Marco;Muzii, LudovicoPenultimo
;Benedetti Panici, PierluigiUltimo
2018
Abstract
The aim of this study was to evaluate the immunohistochemical (IHC) expression of Ki-67, estrogen receptors α (ERsα), and progesterone receptors (PRs) in high-risk endometrial cancer patients and to assess their prognostic impact.| File | Dimensione | Formato | |
|---|---|---|---|
|
Di Donato_Impact-of-Hormone-Receptor_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
4.9 MB
Formato
Adobe PDF
|
4.9 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
